We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

21 hedge funds and large institutions have $1.48M invested in Armata Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

203% more capital invested

Capital invested by funds: $488K → $1.48M (+$992K)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.05M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$91.3K
3
VF
Virtu Financial
New York
+$35.1K
4
Northern Trust
Northern Trust
Illinois
+$16K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$12.7K

Top Sellers

Rank Fund Capital Flow
1
ARTA
A.R.T. Advisors
New York
-$65K
2
Citadel Advisors
Citadel Advisors
Florida
-$18K
3
Renaissance Technologies
Renaissance Technologies
New York
-$16.5K
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$5.07K
5
UBS Group
UBS Group
Switzerland
-$4.08K

ARMP Hedge Fund Activity: Q1 2018 in Review

21 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q1 2018, worth a combined $1.48M — up 203% from $488K a quarter earlier.

Fund positioning in ARMP was balanced in Q1 2018: 5 funds opened new positions, 5 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.05M. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $65K sold.

  • 21 institutional investors held Armata Pharmaceuticals (ARMP) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $1.48M of Armata Pharmaceuticals stock for Q1 2018, up 203% quarter-over-quarter.
  • 5 funds opened new Armata Pharmaceuticals positions in Q1 2018 and 5 closed out, a net change of 0 holders.
  • The largest Armata Pharmaceuticals buyer in Q1 2018 was Sabby Management, an estimated $1.05M added.
  • The largest Armata Pharmaceuticals seller in Q1 2018 was A.R.T. Advisors, an estimated $65K sold.

Based on aggregated 13F filings for Q1 2018.